Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis • May 31, 2020
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’. Ann Rheum Dis • May 28, 2020
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis • May 24, 2020
2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis • June 7, 2017
Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Ann Rheum Dis • February 12, 2014
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis • December 30, 2008
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis • November 17, 2008